Franco-Cereceda A, Gennari C, Nami R, Agnusdei D, Pernow J, Lundberg J M, Fischer J A
Circ Res. 1987 Mar;60(3):393-7. doi: 10.1161/01.res.60.3.393.
Calcitonin gene-related peptide (CGRP) is present in sensory nerve fibers in the heart and around peripheral arteries. On interaction with specific CGRP binding sites and activation of adenylate cyclase, CGRP causes vasodilation and has positive inotropic and chronotropic effects on the heart. In the present study, human CGRP I and II exerted positive inotropic effects on isolated human right auricles and relaxed small arteries from human skeletal muscle precontracted with norepinephrine (EC50 for CGRP I 0.59 nM and for CGRP II 0.37 nM). CGRP I and II (3.2 nmol) administered i.v. to 6 normal subjects exerted positive inotropic actions on the human heart concomitant with positive chronotropic effects, hypotension, and vasodilation. CGRP may, therefore, be of importance for cardiovascular control in man.
降钙素基因相关肽(CGRP)存在于心脏和外周动脉周围的感觉神经纤维中。与特定的CGRP结合位点相互作用并激活腺苷酸环化酶后,CGRP会引起血管舒张,并对心脏产生正性变力和变时作用。在本研究中,人CGRP I和II对分离的人右心耳产生正性变力作用,并使去甲肾上腺素预收缩的人骨骼肌小动脉舒张(CGRP I的EC50为0.59 nM,CGRP II的EC50为0.37 nM)。静脉注射给6名正常受试者的CGRP I和II(3.2 nmol)对人心脏产生正性变力作用,同时伴有正性变时作用、低血压和血管舒张。因此,CGRP可能对人体心血管控制具有重要意义。